Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Latvia

Coordination and Support Action · Running

PMPC Centre of Excellence for Precision Medicine in Pediatric Care

Coordinator
Bernu Kliniska Universitates Slimnica Valsts Sia, Latvia
Runs
1 January 2025 to 31 December 2030
Status
Running
EU funding
€14.4m
Total cost
€14.4m
Partners
2 organisations in 2 countries
Type
Coordination and Support Action
Grant agreement
101136530

What the project is doing

In the project's own words, from its summary on CORDIS.

The vision of the PMPC (“Centre of excellence for precision medicine in pediatric care”) project is to position the Children’s Clinical University Hospital (CCUH) in Latvia at the leading-edge of pediatric precision medicine research and care in Europe. Precision medicine has proven its potential to revolutionize healthcare by tailoring treatments to individual patients based on their unique genetic makeup, environment and lifestyle factors.

While it has shown promise and delivers results in adult populations, its potential in pediatric care is largely untapped. Our goal is to improve pediatric patient care and outcomes by establishing a new research Centre of Excellence (CoE) at CCUH’s campus for research on and adoption of innovative precision medicine approaches in an integrated and collaborative RESEARCH +INNOVATION+CARE+EDUCATION (“R+I+C+E”) environment.

To this end, CCUH will team-up with Europe’s leading institute in pediatric precision medicine: the Princess Maxima Center, The Netherlands. Maxima has an extensive precision medicine program and uses advanced translational research and treatment expertise in many areas, including CAR-T cell therapies and pediatric clinical trials. The CoE will provide an environment for transdisciplinary team science with international visibility in the field of pediatric precision medicine.

The center will leverage the latest advances in genomics, cell therapies, data science, and computational biology. CCUH has secured 20 million EUR from private donors as a complementary part of funding. Together with the Horizon Europe grant, the valuable knowledge/technology transfer and active collaboration with the Maxima team, PMPC’s unique value will be brought forward resulting in benefits for patients, their caregivers, researchers, healthcare professionals and society.

It will strengthen CCUH’s scientific and technological capacity in precision medicine, enabling it to attain a competitive position in this promising field.

Topics

Who is involved

OrganisationCityCountryRole
Bernu Kliniska Universitates Slimnica Valsts SiaRigaLatviaCoordinator
Prinses Maxima Centrum Voor Kinderoncologie BVUtrechtNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI